Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

JAK inhibitors may help improve symptoms in adults with APECED.

B cells can both help and hinder the body's defense against melanoma.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Anti-CD19 therapy may help treat SLE and NMOSD.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Lokivetmab reduced itching in a dog with skin lymphoma.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Targeting PTEN can improve healing in venous leg ulcers.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

AQB reduces harmful skin changes in systemic sclerosis.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

AS101 reduces hair loss from chemotherapy.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Activating TLR3 boosts autophagy gene expression in skin cells.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

CS12192 effectively treats alopecia areata with better safety than current options.